IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism
- PMID: 1903415
IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism
Abstract
Primary cultures of BALB/cJ hepatocytes treated with 10(3) U/ml rIFN-gamma consistently inhibited intracellular Plasmodium berghei liver schizont development by 50 to 70%. Monomethyl-L-arginine (NGMMLA), the competitive inhibitor of L-arginine as substrate for production of nitric oxides by hepatocytes, reversed the activity of IFN-gamma on these malaria-infected cells. Reversal of IFN-gamma activity by NGMMLA was dose dependent and was maximal at 0.5 mM NGMMLA. Depletion of L-arginine by addition of arginase to the culture medium blocked the capacity of IFN-gamma to inhibit parasite development in hepatocytes; addition of excess L-arginine to cultures treated with IFN-gamma in the presence of NGMMLA competitively restored IFN-gamma capacity to activate hepatocyte anti-parasite activity. TNF-alpha was neither required for IFN-gamma activity, nor effective at any concentration tested as an inhibitor of schizont development by itself in primary hepatocytes. These data strongly suggest that the action of IFN-gamma on P. berghei-infected hepatocytes is to induce the production of L-arginine-derived nitrogen oxides that are toxic for the intracellular parasite.
Similar articles
-
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.J Immunol. 1990 Jan 1;144(1):278-83. J Immunol. 1990. PMID: 2104889
-
Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes.Toxicol Appl Pharmacol. 1993 Mar;119(1):100-7. doi: 10.1006/taap.1993.1048. Toxicol Appl Pharmacol. 1993. PMID: 7682342
-
Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.J Immunol. 1990 Dec 15;145(12):4290-7. J Immunol. 1990. PMID: 2124240
-
Macrophage cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism.J Immunol. 1991 Jun 15;146(12):4338-43. J Immunol. 1991. PMID: 1904079
-
Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites.J Immunol. 1995 Apr 1;154(7):3391-5. J Immunol. 1995. PMID: 7534796
Cited by
-
Immunity to liver stage malaria: considerations for vaccine design.Immunol Res. 2003;27(1):53-70. doi: 10.1385/IR:27:1:53. Immunol Res. 2003. PMID: 12637768 Review.
-
Antibody-mediated and cellular immune responses induced in naive volunteers by vaccination with long synthetic peptides derived from the Plasmodium vivax circumsporozoite protein.Am J Trop Med Hyg. 2011 Feb;84(2 Suppl):35-42. doi: 10.4269/ajtmh.2011.09-0507. Am J Trop Med Hyg. 2011. PMID: 21292876 Free PMC article.
-
Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.Infect Immun. 1994 Jul;62(7):2979-83. doi: 10.1128/iai.62.7.2979-2983.1994. Infect Immun. 1994. PMID: 8005684 Free PMC article.
-
SARS-CoV-2 decreases malaria severity in co-infected rodent models.Front Cell Infect Microbiol. 2023 Dec 13;13:1307553. doi: 10.3389/fcimb.2023.1307553. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38156320 Free PMC article.
-
Dendritic cells can initiate protective immune responses against malaria.Infect Immun. 2001 Aug;69(8):5173-6. doi: 10.1128/IAI.69.8.5173-5176.2001. Infect Immun. 2001. PMID: 11447201 Free PMC article.